APO RESEARCH · REPORT
Vinca Alkaloid Compounds
Vinca alkaloids are a set of anti-mitotic and anti-microtubule alkaloid agents originally derived from the periwinkle plant Catharanthus roseus (basionym Vinca rosea) and other vinca plants.
Product & engineering
Understand the product.
Vinca alkaloids are a set of anti-mitotic and anti-microtubule alkaloid agents originally derived from the periwinkle plant Catharanthus roseus (basionym Vinca rosea) and other vinca plants.
Selected research
Industry Research
Vinca Alkaloid Compounds Industry Research Report 2026
Market perspective
Vinca alkaloids are a set of anti-mitotic and anti-microtubule alkaloid agents originally derived from the periwinkle plant Catharanthus roseus (basionym Vinca rosea) and other vinca plants.
China is the largest vinca alkaloid compounds market with about 53% market share. Europe and North America is follower, accounting for both about 15% market share.
The key players are Pierre Fabre, Minakem, Guangzhou Hanfang Pharmaceutical etc. Top 3 companies occupied about 40% market share.
Read the full market overview
Report Scope
This report quantifies the global Vinca Alkaloid Compounds market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Vinca Alkaloid Compounds Market by Company
Pierre Fabre
Minakem
Guangzhou Hanfang Pharmaceutical
Hainan Vinca biological medicine technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Vinkem
Hansoh
Min Sheng
Zhendong Group
Vinca Alkaloid Compounds Segment by Type
Vincristine
Vinorelbine
Vindesine
Vinca Alkaloid Compounds Segment by Application
Lymphoma
Breast Cancer
Lung Cancer
Others
Vinca Alkaloid Compounds Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vinca Alkaloid Compounds market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vinca Alkaloid Compounds and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vinca Alkaloid Compounds.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vinca Alkaloid Compounds manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vinca Alkaloid Compounds by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vinca Alkaloid Compounds in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vincristine
- Vinorelbine
- Vindesine
Applications
- Lymphoma
- Breast Cancer
- Lung Cancer
- Others
Companies covered
- Pierre Fabre
- Minakem
- Guangzhou Hanfang Pharmaceutical
- Hainan Vinca biological medicine technology
- Guangzhou Person Pharmaceutical
- Hainan Yueyang Biotechnology
- Hubei Honch Pharmaceutical
- Fine Chemicals Corporation
- Vinkem
- Hansoh
- Min Sheng
- Zhendong Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Vinca Alkaloid Compounds Market Size (2021-2032)
- 2.2.2 Global Vinca Alkaloid Compounds Sales (2021-2032)
- 2.2.3 Global Vinca Alkaloid Compounds Market Average Price (2021-2032)
- 2.3 Vinca Alkaloid Compounds by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Vincristine
- 2.3.3 Vinorelbine
- 2.3.4 Vindesine
- 2.4 Vinca Alkaloid Compounds by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Lymphoma
- 2.4.3 Breast Cancer
- 2.4.4 Lung Cancer
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Vinca Alkaloid Compounds Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Vinca Alkaloid Compounds Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Vinca Alkaloid Compounds Revenue of Manufacturers (2021-2026)
- 3.4 Global Vinca Alkaloid Compounds Average Price by Manufacturers (2021-2026)
- 3.5 Global Vinca Alkaloid Compounds Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Vinca Alkaloid Compounds, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Vinca Alkaloid Compounds, Product Type & Application
- 3.8 Global Manufacturers of Vinca Alkaloid Compounds, Established Date
- 3.9 Global Vinca Alkaloid Compounds Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pierre Fabre
- 4.1.1 Pierre Fabre Company Information
- 4.1.2 Pierre Fabre Business Overview
- 4.1.3 Pierre Fabre Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pierre Fabre Vinca Alkaloid Compounds Product Portfolio
- 4.1.5 Pierre Fabre Recent Developments
- 4.2 Minakem
- 4.2.1 Minakem Company Information
- 4.2.2 Minakem Business Overview
- 4.2.3 Minakem Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Minakem Vinca Alkaloid Compounds Product Portfolio
- 4.2.5 Minakem Recent Developments
- 4.3 Guangzhou Hanfang Pharmaceutical
- 4.3.1 Guangzhou Hanfang Pharmaceutical Company Information
- 4.3.2 Guangzhou Hanfang Pharmaceutical Business Overview
- 4.3.3 Guangzhou Hanfang Pharmaceutical Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Guangzhou Hanfang Pharmaceutical Vinca Alkaloid Compounds Product Portfolio
- 4.3.5 Guangzhou Hanfang Pharmaceutical Recent Developments
- 4.4 Hainan Vinca biological medicine technology
- 4.4.1 Hainan Vinca biological medicine technology Company Information
- 4.4.2 Hainan Vinca biological medicine technology Business Overview
- 4.4.3 Hainan Vinca biological medicine technology Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hainan Vinca biological medicine technology Vinca Alkaloid Compounds Product Portfolio
- 4.4.5 Hainan Vinca biological medicine technology Recent Developments
- 4.5 Guangzhou Person Pharmaceutical
- 4.5.1 Guangzhou Person Pharmaceutical Company Information
- 4.5.2 Guangzhou Person Pharmaceutical Business Overview
- 4.5.3 Guangzhou Person Pharmaceutical Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Guangzhou Person Pharmaceutical Vinca Alkaloid Compounds Product Portfolio
- 4.5.5 Guangzhou Person Pharmaceutical Recent Developments
- 4.6 Hainan Yueyang Biotechnology
- 4.6.1 Hainan Yueyang Biotechnology Company Information
- 4.6.2 Hainan Yueyang Biotechnology Business Overview
- 4.6.3 Hainan Yueyang Biotechnology Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hainan Yueyang Biotechnology Vinca Alkaloid Compounds Product Portfolio
- 4.6.5 Hainan Yueyang Biotechnology Recent Developments
- 4.7 Hubei Honch Pharmaceutical
- 4.7.1 Hubei Honch Pharmaceutical Company Information
- 4.7.2 Hubei Honch Pharmaceutical Business Overview
- 4.7.3 Hubei Honch Pharmaceutical Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hubei Honch Pharmaceutical Vinca Alkaloid Compounds Product Portfolio
- 4.7.5 Hubei Honch Pharmaceutical Recent Developments
- 4.8 Fine Chemicals Corporation
- 4.8.1 Fine Chemicals Corporation Company Information
- 4.8.2 Fine Chemicals Corporation Business Overview
- 4.8.3 Fine Chemicals Corporation Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Fine Chemicals Corporation Vinca Alkaloid Compounds Product Portfolio
- 4.8.5 Fine Chemicals Corporation Recent Developments
- 4.9 Vinkem
- 4.9.1 Vinkem Company Information
- 4.9.2 Vinkem Business Overview
- 4.9.3 Vinkem Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Vinkem Vinca Alkaloid Compounds Product Portfolio
- 4.9.5 Vinkem Recent Developments
- 4.10 Hansoh
- 4.10.1 Hansoh Company Information
- 4.10.2 Hansoh Business Overview
- 4.10.3 Hansoh Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hansoh Vinca Alkaloid Compounds Product Portfolio
- 4.10.5 Hansoh Recent Developments
- 4.11 Min Sheng
- 4.11.1 Min Sheng Company Information
- 4.11.2 Min Sheng Business Overview
- 4.11.3 Min Sheng Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Min Sheng Vinca Alkaloid Compounds Product Portfolio
- 4.11.5 Min Sheng Recent Developments
- 4.12 Zhendong Group
- 4.12.1 Zhendong Group Company Information
- 4.12.2 Zhendong Group Business Overview
- 4.12.3 Zhendong Group Vinca Alkaloid Compounds Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Zhendong Group Vinca Alkaloid Compounds Product Portfolio
- 4.12.5 Zhendong Group Recent Developments
5 Global Vinca Alkaloid Compounds Market Scenario by Region
- 5.1 Global Vinca Alkaloid Compounds Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Vinca Alkaloid Compounds Sales by Region: 2021-2032
- 5.2.1 Global Vinca Alkaloid Compounds Sales by Region: 2021-2026
- 5.2.2 Global Vinca Alkaloid Compounds Sales by Region: 2027-2032
- 5.3 Global Vinca Alkaloid Compounds Revenue by Region: 2021-2032
- 5.3.1 Global Vinca Alkaloid Compounds Revenue by Region: 2021-2026
- 5.3.2 Global Vinca Alkaloid Compounds Revenue by Region: 2027-2032
- 5.4 North America Vinca Alkaloid Compounds Market Facts & Figures by Country
- 5.4.1 North America Vinca Alkaloid Compounds Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Vinca Alkaloid Compounds Sales by Country (2021-2032)
- 5.4.3 North America Vinca Alkaloid Compounds Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Vinca Alkaloid Compounds Market Facts & Figures by Country
- 5.5.1 Europe Vinca Alkaloid Compounds Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Vinca Alkaloid Compounds Sales by Country (2021-2032)
- 5.5.3 Europe Vinca Alkaloid Compounds Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Vinca Alkaloid Compounds Market Facts & Figures by Country
- 5.6.1 Asia Pacific Vinca Alkaloid Compounds Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Vinca Alkaloid Compounds Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Vinca Alkaloid Compounds Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Vinca Alkaloid Compounds Market Facts & Figures by Country
- 5.7.1 South America Vinca Alkaloid Compounds Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Vinca Alkaloid Compounds Sales by Country (2021-2032)
- 5.7.3 South America Vinca Alkaloid Compounds Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Vinca Alkaloid Compounds Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Vinca Alkaloid Compounds Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Vinca Alkaloid Compounds Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Vinca Alkaloid Compounds Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Vinca Alkaloid Compounds Sales by Type (2021-2032)
- 6.1.1 Global Vinca Alkaloid Compounds Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Vinca Alkaloid Compounds Sales Market Share by Type (2021-2032)
- 6.2 Global Vinca Alkaloid Compounds Revenue by Type (2021-2032)
- 6.2.1 Global Vinca Alkaloid Compounds Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Vinca Alkaloid Compounds Revenue Market Share by Type (2021-2032)
- 6.3 Global Vinca Alkaloid Compounds Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Vinca Alkaloid Compounds Sales by Application (2021-2032)
- 7.1.1 Global Vinca Alkaloid Compounds Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Vinca Alkaloid Compounds Sales Market Share by Application (2021-2032)
- 7.2 Global Vinca Alkaloid Compounds Revenue by Application (2021-2032)
- 7.2.1 Global Vinca Alkaloid Compounds Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Vinca Alkaloid Compounds Revenue Market Share by Application (2021-2032)
- 7.3 Global Vinca Alkaloid Compounds Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Vinca Alkaloid Compounds Value Chain Analysis
- 8.1.1 Vinca Alkaloid Compounds Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Vinca Alkaloid Compounds Production Mode & Process
- 8.2 Vinca Alkaloid Compounds Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Vinca Alkaloid Compounds Distributors
- 8.2.3 Vinca Alkaloid Compounds Customers
9 Global Vinca Alkaloid Compounds Analyzing Market Dynamics
- 9.1 Vinca Alkaloid Compounds Industry Trends
- 9.2 Vinca Alkaloid Compounds Industry Drivers
- 9.3 Vinca Alkaloid Compounds Industry Opportunities and Challenges
- 9.4 Vinca Alkaloid Compounds Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst